TY-0609
/ TYK Medicines
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 25, 2026
TYK Medicines…is pleased to announce that the research progress and results for five innovative drug projects under development of the Company, namely TY-0609 (CDK4 inhibitor), TY-2699a (CDK7 inhibitor), TY-2719 (EGFR/FAK (PROTAC) inhibitor), PI3Kα (PI3Kα inhibitor), and TY-1054 (YAP-TEAD inhibitor), will be presented by the Company in poster presentation at 2026…AACR annual meeting
(HKEXnews)
Preclinical • Solid Tumor
1 to 1
Of
1
Go to page
1